49 completed. 49 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 49 | Completed 49 |
| Phase 2 | 9 | Completed 9 |
Follow Vomiting: new trials by email Literature Review of Vomiting trials Research Report on Vomiting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I PK and Safety Study of Ondansetron Inhalation Powder LPI-1503, Matching Placebo of LPI-1503, IV Ondansetron - Postoperative Nausea and Vomiting | Phase 1 | Completed | Luxena Pharmaceuticals, Inc. | 24 | 2025-03-13 | 2026-03-27 |
| Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery | Phase 1 / Phase 2 | Completed | Ziauddin University | 60 | 2025-01-06 | 2026-09-02 |
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation Glycopyrrolate, Anisodamine - Nausea and Vomiting | Phase 1 / Phase 2 | Completed | Jie Chen | 130 | 2023-10-01 | 2024-09-05 |
| Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children Dexamethasone, Ondansetron, Dexmedetomidine - Postoperative Nausea and Vomiting, Post Operative Pain | Phase 1 | Completed | Tanta University | 4 | 2021-10-27 | 2022-04-05 |
| Olanzapine for the Prevention of Postoperative Nausea and Vomiting Placebo, 5 mg Olanzapine Tablets, 10 mg Olanzapine Tablets - Postoperative Nausea | Phase 1 / Phase 2 | Completed | Amani Hassan Abdel-Wahab | 132 | 2021-03-15 | 2023-03-09 |
| The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy Cannabidiol - Lean Body Mass, Cannabis | Phase 1 | Completed | University of Copenhagen | 32 | 2020-12-01 | 2023-07-24 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S QBS10072S - Astrocytoma, Brain Cancer | Phase 1 | Completed | Quadriga Biosciences, Inc. | 15 | 2020-07-20 | 2023-01-18 |
| Study of APD421 With and Without Ondansetron APD421, Placebo, Ondansetron - Postoperative Nausea and Vomiting | Phase 1 | Completed | Acacia Pharma Ltd | 30 | 2018-07-17 | 2018-10-01 |
| Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers Aprepitant Capsule 125 MG, Aprepitant oral suspension 20 mg/mL - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | The Hospital for Sick Children | 17 | 2017-08-10 | 2022-04-11 |
| Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride Chlorpromazine Hydrochloride - Anti-Psychotic, Management of Manifestations of Psychotic Disorders | Phase 1 | Completed | Cycle Pharmaceuticals Ltd. | 20 | 2016-11-01 | 2017-11-14 |
| Mass-balance Study of [14C]-APD421 in Healthy Volunteers 14C-APD421 - Post-operative Nausea and Vomiting | Phase 1 | Completed | Acacia Pharma Ltd | 6 | 2016-08-01 | 2019-06-25 |
| Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers GNS Spray 0.5mg, GNS Spray 1.0mg, GNS Spray 2.0mg - Cancer | Phase 1 | Completed | Maxinase Life Sciences Ltd. | 50 | 2015-09-01 | 2016-01-08 |
| A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route CL-108, M366, Placebo - Pain, Nausea | Phase 1 | Completed | Charleston Laboratories, Inc | 40 | 2015-06-01 | 2019-10-14 |
| An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects Rolapitant, Digoxin, Sulfasalazine - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | Tesaro, Inc. | 102 | 2015-05-01 | 2015-08-25 |
| A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers Rolapitant - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | Tesaro, Inc. | 100 | 2015-01-01 | 2015-08-25 |
| An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant Rolapitant - Oral, Rolapitant - IV - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | Tesaro, Inc. | 138 | 2014-09-01 | 2015-08-25 |
| Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting Ondansetron with1:1 ORA - sweet. - Gastroenteritis | Phase 1 | Completed | Hamad Medical Corporation | 40 | 2014-09-01 | 2015-06-17 |
| How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women Ondansetron - Postoperative Nausea | Phase 1 / Phase 2 | Completed | Stanford University | 100 | 2013-01-01 | 2015-06-01 |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years granisetron transdermal system, Granisetron IV - Chemotherapy Induced Nausea and Vomiting | Phase 1 | Completed | Kyowa Kirin Pharmaceutical Development Ltd | 19 | 2012-05-01 | 2024-06-17 |
| Acupuncture Treatment for Gastroparesis: a Pilot Study Acupuncture for gastroparesis, Acupuncture for musculoskeletal pain - Gastroparesis, Nausea | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 20 | 2011-11-01 | 2016-09-02 |
Showing 20 of 49. Sign in to see all of them.
Nausea (23) · Postoperative Nausea and Vomiting (11) · Anorexia (3) · Neoplasms (3) · Brain Neoplasms (2) · Breast Neoplasms (2) · Gastroparesis (2) · Melanoma (2) · Pain (2) · Abdominal Pain (1) · Appetitive Behavior (1) · Astrocytoma (1) · Cachexia (1) · Cholangiocarcinoma (1)
Pathological Conditions, Signs and Symptoms (49) · Signs and Symptoms (49) · Signs and Symptoms, Digestive (49) · Pathologic Processes (12) · Postoperative Complications (11) · Nausea (9) · Neurologic Manifestations (7) · Digestive System Diseases (6) · Gastrointestinal Diseases (4) · Neoplasms by Site (4) · Nervous System Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Neoplasms (3)
Ondansetron (14) · casopitant (9) · Aprepitant (6) · Dexamethasone (3) · Granisetron (3) · Tablets (3) · rolapitant (3) · Ketoconazole (2) · Palonosetron (2) · halofantrine (2) · Acupressure (1) · Acupuncture Therapy (1) · Cannabidiol (1) · Chlorpromazine (1) · Control Groups (1)
GlaxoSmithKline (10) · Merck Sharp & Dohme LLC (6) · Tesaro, Inc. (3) · Acacia Pharma Ltd (2) · Sandoz (2) · Accenture (1) · Amani Hassan Abdel-Wahab (1) · Charleston Laboratories, Inc (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · Cycle Pharmaceuticals Ltd. (1) · Duke University (1) · Hamad Medical Corporation (1) · Jie Chen (1) · Johns Hopkins University (1) · Kyowa Kirin Pharmaceutical Development Ltd (1)
United States (22) · Australia (2) · Canada (2) · Spain (2) · Brazil (1) · China (1) · Denmark (1) · Egypt (1) · India (1) · Mexico (1) · Netherlands (1) · Pakistan (1) · Saudi Arabia (1) · South Africa (1) · Taiwan (1)
Dennis Vargo, MD (3) · Soran Hong, M.D. (2) · Agop Y. Bedikian, MD (1) · Amani H Abdel-wahab, MD (1) · Anh D Dang, PhD (1) · Belen Sadaba, MD, PhD (1) · Bernard P Schachtel, M.D (1) · Christine M. Walko, PharmD, BCOP (1) · David R. Drover, MD (1) · Deborah H Allen, MSN, RN, CNS, FNP-BC, AOCNP (1) · Dr Asma A Salam, MBBS, FCPS (1)
PMID 17513629, PMID 19205754, PMID 19617379, PMID 20220045, PMID 22096279, PMID 22245954, PMID 22520120, PMID 22739139, PMID 23904932, PMID 24587006, PMID 25670522, PMID 25885838, PMID 27121336, PMID 31303716, PMID 31694495, PMID 31819674, PMID 31862004, PMID 31913911, PMID 32839657, PMID 40856942
2008 (2), P30CA016086 (1), R43AT004489 (1)